BIO P170 – ARM HYPERPIGMENTATION STUDY – Multiple Groups w/New Dates


BIO P170 – ARM HYPERPIGMENTATION STUDY – Multiple Groups w/New Dates
Posted  June 7, 2024

START DATE06/21/2024
QUALIFICATIONSFemales Ages: 25-65
TIME REQUIREMENT4 visits
COMPENSATION$250

Prescreening is required in our BIO Department. Come in anytime to prescreen. 

This study is now recruiting up to age 65. Please see revised start dates below. 

Conflicting Studies: Dansyl Arm Treatment or any Body wash studies.

Study Description:

Visit 1: Panelists will report to ECRL with a clean, product-free test site. Inclusion and exclusion criteria will be verified and informed consent will be obtained. Visual Grading and Lifestyle Photos will be obtained. Products and daily diaries will be distributed.

Visit 2-Visit 3: Panelists will report to ECRL with a clean, product-free test site. Visual Grading will be obtained.

Visit 4: Panelists will report to ECRL with a clean, product-free test site. Visual Grading and Lifestyle Photos and questionnaires will be obtained. Diary and product will be collected at completion.

Inclusion Criteria:

  • Subject is female between the ages of 25-65
  • Subject has mild to moderate hyperpigmentation on the arm
  • Subject agrees to wear clothing that easily allows access to the test site (arms: elbow to shoulder)
  • Subject agrees not to introduce any new cosmetic or toiletry products during the study
  • Subject is dependable and able to follow directions as outlined in the protocol and anticipates being available for all study visits
  • Subject is willing to stop all products on the test site and use only the products provided for the duration of the study
  • Subject is willing to participate in all study evaluations
  • Subject is in generally good health and has a current Panelist Profile Form on file at ECRL
  • Subject agrees to sign a Photography Release, providing consent for the capture of digital images for use in relation to this clinical study

 

Exclusion Criteria:

  • Subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control;
  • Subject is currently using or have used in the past week any systemic or topical corticosteroids, non-steroid anti-inflammatory drugs, antihistamines, sympathomimetics, and/or vasoconstrictors or any medication that, in the opinion of the Principal Investigator, preclude application of the test material and/or could influence the outcome of the study
  • Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs;
  • Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would, in the opinion of the Principal Investigator, preclude application of the test material and/or could influence the outcome of the study
  • Subject exhibits irritation, tattoos, sunburn, rashes, scratches, burn marks, scarring, etc. on the test site, which might interfere with evaluations of test results
  • Subject is currently taking any medications which, in the opinion of the Principal Investigator, may interfere with the study
  • Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind
  • Subject has diabetes

 

GROUP 1:
V1:    FRI. –    6/21 – 1.5 HRS.
V2:   WED. –    7/3 – 1 HR.
V3:   WED. –    7/19 – 1 HR.
V4:   FRI. –    8/16 – 1 HR.

Appointment Availability

8:00 AM – 4:00 PM

 

GROUP 2:
V1:    MON. –    7/8 – 1.5 HRS.
V2:   MON. –    7/22 – 1 HR.
V3:   MON. –    8/5 – 1 HR.
V4:   TUES. –    9/3 – 1 HR.

Appointment Availability

8:00 AM  – 4:00 PM

 

GROUP 3:
V1:   TUES. –      7/9 – 1.5 HRS.
V2:   TUES. –      7/23 – 1 HR.
V3:   TUES. –     8/6 – 1 HR.
V4:   WED. –      9/4 – 1 HR.

Appointment Availability

8:00 AM  – 4:00 PM

 

Speak to a Recruiter for more information. 




Sign up today!